Palavras-chave
Disbiose
Insuficiência Renal Crônica
Como Citar
Copyright © | Todos os direitos reservados.
A revista detém os direitos autorais exclusivos de publicação deste artigo nos termos da lei 9610/98.
Reprodução parcial
É livre o uso de partes do texto, figuras e questionário do artigo, sendo obrigatória a citação dos autores e revista.
Reprodução total
É expressamente proibida, devendo ser autorizada pela revista.
Resumo
Objetivo: Avaliar a relação entre as alterações no microbioma intestinal e a progressão da doença renal crônica (DRC), bem como as complicações associadas e as potenciais intervenções terapêuticas voltadas ao microbioma intestinal que poderiam ser efetivas. Métodos: Trata-se de uma Revisão Integrativa, realizada por meio da plataforma de base de dados PubMed, com o intento de localizar fontes relevantes para o estudo. A pesquisa foi realizada através da estratégia de pesquisa (("Gastrointestinal Microbiome"[MeSH]) OR (Gut Microbiome)) AND ("Renal Insufficiency, Chronic"[MeSH]), para a busca dos artigos, resultando em 309 artigos iniciais. Dentre esses, devido aos critérios de inclusão e exclusão, 20 tornaram-se fontes oficiais. Resultados: Os estudos apontam que há uma estreita relação entre a microbiota intestinal e a progressão da Doença Renal Crônica, em que a modulação do eixo intestino-rim é um potencial alvo terapêutico. Considerações finais: A relação entre a microbiota intestinal e a DRC é evidente, porém, mais pesquisas na área são necessárias para esclarecimento e confirmação das hipóteses.
Referências
CHEN H, et al. Alterations of gut microbes and their correlation with clinical features in middle and end-stages chronic kidney disease. Front. Cell. Infect. Microbiol, 2023; 13: 1105366.
CHI M, et al. The Immunomodulatory Effect of the Gut Microbiota in Kidney Disease. J Immunol Res. 2021; 1-16.
COSOLA C, et al. Microbiota issue in CKD: how promising are gut-targeted approaches?. J Nephrol, 2019; 32(1): 27-37.
GLORIEUX G, et al. Gut-derived metabolites and their role in immune dysfunction in chronic kidney disease. Toxins, 2020; 12(4): 245.
HOBBY GP, et al. Chronic kidney disease and the gut microbiome. American Journal of Physiology-Renal Physiology, 2019; 316(6): 1211-1217.
HSU CN, et al. Chronic Kidney Disease and Gut Microbiota: What Is Their Connection in Early Life? Int J Mol Sci, 2022; 23(7): 3954.
HU X, et al. Characterizing the gut microbiota in patients with chronic kidney disease. Postgraduate medicine, 2020; 132(6): 495-505.
IGUCHI A, et al. Effect of sucroferric oxyhydroxide on gastrointestinal microbiome and uremic toxins in patients with chronic kidney disease undergoing hemodialysis. Clin Exp Nephrol, 2020; 24: 725–733.
KIM SM, SONG IH. The clinical impact of gut microbiota in chronic kidney disease. Korean J Intern Med, 2020; 35(6): 1305-1316.
LI F, et al. Alterations to the Gut Microbiota and Their Correlation With Inflammatory Factors in Chronic Kidney Disease. Front Cell Infect Microbiol, 2019; 9: 206.
LI N, et al. Causal Effects of Specific Gut Microbiota on Chronic Kidney Diseases and Renal Function—A Two-Sample Mendelian Randomization Study. Nutrients, 2023; 15(2): 360.
LIU F, et al. Alteration of the Gut Microbiome in Chronic Kidney Disease Patients and Its Association With Serum Free Immunoglobulin Light Chains. Front Immunol, 2021; 12: 609700.
LOHIA S, et al. Microbiome in Chronic Kidney Disease (CKD): An Omics Perspective. Toxins, 2022; 14(3): 176.
LUN H, et al. Altered gut microbiota and microbial biomarkers associated with chronic kidney disease. Microbiologyopen, 2019; 8(4): e00678.
MERTOWSKA P, et al. A Link between Chronic Kidney Disease and Gut Microbiota in Immunological and Nutritional Aspects. Nutrients, 2021; 13(10): 3637.
MIKUSIC NLR, et al. Gut microbiota and chronic kidney disease: evidences and mechanisms that mediate a new communication in the gastrointestinal-renal axis. Pflugers Arch, 2020; 472(3): 303-320.
NOCE A, et al. Link between gut microbiota dysbiosis and chronic kidney disease. European Review for Medical and Pharmacological Sciences, 2022; 26(6): 2057-2074.
RANGANATHAN N, ANTEYI E. The Role of Dietary Fiber and Gut Microbiome Modulation in Progression of Chronic Kidney Disease. Toxins, 2022; 14(3): 183.
RYSZ J, et al .The Impact of CKD on Uremic Toxins and Gut Microbiota. Toxins, 2021; 13(4): 252.
SARANYA GR, VISWANATHAN P. Gut microbiota dysbiosis in AKI to CKD transition. Biomedicine & Pharmacotherapy, 2023; 161: 114447.
SNELSON M, et al. Modulation of the Gut Microbiota by Resistant Starch as a Treatment of Chronic Kidney Diseases: Evidence of Efficacy and Mechanistic Insights. Adv Nutr, 2019; 10(2): 303-320.
TAGUCHI K, et al. Dysbiosis-Related Advanced Glycation Endproducts and Trimethylamine N-Oxide in Chronic Kidney Disease. Toxins (Basel), 2021; 13(5): 361.
TIAN N, et al. The Potential Benefits and Controversies of Probiotics Use in Patients at Different Stages of Chronic Kidney Disease. Nutrients, 2022; 14(19): 4044.
WANG H, et al. Perturbed gut microbiome and fecal and serum metabolomes are associated with chronic kidney disease severity. Microbiome, 2023; 11(1): 3.
WU IW, et al. Integrative metagenomic and metabolomic analyses reveal severity-specific signatures of gut microbiota in chronic kidney disease. Theranostics, 2020; 10(12): 5398-5411.
YANG C-Y, et al. Synbiotics Alleviate the Gut Indole Load and Dysbiosis in Chronic Kidney Disease. Cells, 2021; 10(1): 114.
ZHAO J, et al. Specific alterations in gut microbiota in patients with chronic kidney disease: an updated systematic review. Ren Fail, 2021; 43(1): 102-112.